Beyond Basic Beta Content Hub Expect Pharmaceuticals M&A Activity to Rebound After COVID-19 Eases By Tom LydonApril 17, 2020
ETF Strategist Content Hub A Look at the S&P Sectors from 2019 By Canterbury Investment ManagementJanuary 8, 2020
Relative Value Content Hub Could Coiled Volatility Suggest A Bigger Stock Move Is Coming? By Ian YoungNovember 11, 2019
Core Equity Content Hub Markets Bounce Back to Close Week Near Record Highs By Ian YoungNovember 8, 2019
Beyond Basic Beta Content Hub 8 ETFs to Capture Opportunities in Healthcare Sector By Max ChenAugust 22, 2019
Innovative ETFs Content Hub AbbVie, Allergan Deal Puts Spotlight on Pharmaceutical ETFs By Max ChenJune 25, 2019
Beyond Basic Beta Content Hub 4 ETFs to Consider with Big Pharma on the Senate’s Hot Seat By Ben HernandezApril 9, 2019
Innovative ETFs Content Hub Pharmaceutical ETFs Break Out on Horizon Pharma’s Positive Drug Results By Max ChenFebruary 28, 2019
